Compensatory T-type Ca2+ channel activity alters D2-autoreceptor responses of Substantia nigra dopamine neurons from Cav1.3 L-type Ca2+ channel KO mice

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Poetschke, Christina ^a   Dragicevic, Elena ^a   Duda, Johanna ^a   Benkert, Julia ^a   Dougalis, Antonios ^a   DeZio, Roberta ^a   Snutch, Terrance P ^b   Striessnig, Joerg ^c   Liss, Birgit ^a  

^a UNIVERSITY OF ULM   (Germany)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

AUTORECEPTOR; CACNA1D PROTEIN, MOUSE; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL L TYPE; CALCIUM CHANNEL T TYPE; DOPAMINE 2 RECEPTOR; FREQUENIN CALCIUM SENSOR PROTEINS; MESSENGER RNA; NEURONAL CALCIUM SENSOR; NEUROPEPTIDE;

AGE; ANIMAL; DEFICIENCY; DOPAMINERGIC NERVE CELL; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; KNOCKOUT MOUSE; MALE; MEMBRANE POTENTIAL; METABOLISM; MOUSE; PARKINSON DISEASE; PHENOTYPE; SUBSTANTIA NIGRA;

AGE FACTORS; ANIMALS; AUTORECEPTORS; CALCIUM; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, L-TYPE; CALCIUM CHANNELS, T-TYPE; DOPAMINERGIC NEURONS; GENE EXPRESSION REGULATION; MALE; MEMBRANE POTENTIALS; MICE; MICE, KNOCKOUT; NEURONAL CALCIUM-SENSOR PROTEINS; NEUROPEPTIDES; PARKINSON DISEASE; PHENOTYPE; RECEPTORS, DOPAMINE D2; RNA, MESSENGER; SUBSTANTIA NIGRA;

EID: 84942057993     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep13688     Document Type: Article

References (67)

1. Braak, H. et al. Stages in the development of Parkinson's disease-related pathology. Cell and tissue research 318, 121-134 (2004).
2. Hindle, J. V. Ageing, neurodegeneration and Parkinson's disease. Age Ageing 39, 156-161 (2010).
3. Trudeau, L. E. et al. The multilingual nature of dopamine neurons. Progress in brain research 211, 141-164 (2014).
4. Sulzer, D. & Surmeier, D. J. Neuronal vulnerability, pathogenesis, and Parkinson's disease. Mov Disord 28, 41-50 (2013).
5. Guzman, J. N. et al. Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1. Nature 468, 696-700 (2010).
6. Surmeier, D. J., Guzman, J. N., Sanchez-Padilla, J. & Goldberg, J. A. The origins of oxidant stress in Parkinson's disease and therapeutic strategies. Antioxid Redox Signal 14, 1289-1301 (2011).
7. Pasternak, B. et al. Use of calcium channel blockers and Parkinson's disease. Am J Epidemiol 175, 627-635 (2012).
8. Ritz, B. et al. L-type calcium channel blockers and Parkinson disease in Denmark. Ann Neurol 67, 600-606 (2010).
9. Kupsch, A. et al. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in non-human primates is antagonized by pretreatment with nimodipine at the nigral, but not at the striatal level. Brain research 741, 185-196 (1996).
10. Ilijic, E., Guzman, J. N. & Surmeier, D. J. The L-type channel antagonist isradipine is neuroprotective in a mouse model of Parkinson's disease. Neurobiol Dis 43, 364-371 (2011).
11. Dragicevic, E. et al. Cav1.3 channels control D2-autoreceptor responses via NCS-1 in substantia nigra dopamine neurons. Brain (2014).
12. 2+ channels is dependent on a Shankbinding domain. J Neurosci 25, 1050-1062 (2005).
13. Helton, T. D., Xu, W. & Lipscombe, D. Neuronal L-type calcium channels open quickly and are inhibited slowly. J Neurosci 25, 10247-10251 (2005).
14. Striessnig, J. et al. L-type Ca channels in heart and brain. Wiley interdisciplinary reviews Membrane transport and signaling 3, 15-38 (2014).
15. Kang, S. et al. CaV1.3-selective L-type calcium channel antagonists as potential new therapeutics for Parkinson's disease. Nat Commun 3, 1146 (2012).
16. Brimblecombe, K. R., Gracie, C. J., Platt, N. J. & Cragg S. J. Gating of dopamine transmission by calcium and axonal N-, Q-, T- and L-type voltage-gated calcium channels differs between striatal domains. J Physiol 593, 929-946 (2015).
17. Chan, C. S. et al. 'Rejuvenation' protects neurons in mouse models of Parkinson's disease. Nature 447, 1081-1086 (2007).
18. Drion, G., Massotte, L., Sepulchre, R. & Seutin, V. How modeling can reconcile apparently discrepant experimental results: the case of pacemaking in dopaminergic neurons. PLoS Comput Biol 7, e1002050 (2011).
19. Guzman, J. N., Sanchez-Padilla, J., Chan, C. S. & Surmeier, D. J. Robust pacemaking in substantia nigra dopaminergic neurons. J Neurosci 29, 11011-11019 (2009).
20. Luscher, C. & Slesinger, P. A. Emerging roles for G protein-gated inwardly rectifying potassium (GIRK) channels in health and disease. Nat Rev Neurosci 11, 301-315 (2010).
21. Beaulieu, J. M. & Gainetdinov, R. R. The physiology, signaling, and pharmacology of dopamine receptors. Pharmacol Rev 63, 182-217 (2011).
22. Burgoyne, R. D. & Haynes, L. P. Sense and specificity in neuronal calcium signalling. Biochimica et biophysica acta, doi: 10.1016/j. bbamcr.2014.1010.1029 (2014).
23. Simms, B. A. & Zamponi, G. W. Neuronal voltage-gated calcium channels: structure, function, and dysfunction. Neuron 82, 24-45 (2014).
24. 2+ channels in cardiac pacemaker activity. Proc Natl Acad Sci USA 100, 5543-5548 (2003).
25. 2+ channels. J Clin Invest 113, 1430-1439 (2004).
26. Saab, B. J. et al. NCS-1 in the dentate gyrus promotes exploration, synaptic plasticity, and rapid acquisition of spatial memory. Neuron 63, 643-656 (2009).
27. Tringham, E. et al. T-type calcium channel blockers that attenuate thalamic burst firing and suppress absence seizures. Sci Transl Med 4, 121ra119 (2012).
28. 2+ channels contributes to the irregular firing of dopamine neurons in neonatal rats. J Neurosci 24, 11079-11087 (2004).
29. Pedarzani, P. & Stocker, M. Molecular and cellular basis of small-and intermediate-conductance, calcium-activated potassium channel function in the brain. Cell Mol Life Sci 65, 3196-3217 (2008).
30. Wolfart, J. & Roeper, J. Selective coupling of T-type calcium channels to SK potassium channels prevents intrinsic bursting in dopaminergic midbrain neurons. J Neurosci 22, 3404-3413 (2002).
31. Brevi, S., de Curtis, M. & Magistretti, J. Pharmacological and biophysical characterization of voltage-gated calcium currents in the endopiriform nucleus of the guinea pig. J Neurophysiol 85, 2076-2087 (2001).
32. Bishop, M. W. et al. Hyperexcitable substantia nigra dopamine neurons in PINK1- and HtrA2/Omi-deficient mice. J Neurophysiol 104, 3009-3020 (2010).
33. Hille, B. Ion Channels of Excitable Membranes, Third edn. Sunderland, MA: Sinauer Associates (2001).
34. Cain, S. M. & Snutch, T. P. Contributions of T-type calcium channel isoforms to neuronal firing. Channels (Austin) 4, 475-482 (2010).
35. Lieb, A., Ortner, N. & Striessnig, J. C-terminal modulatory domain controls coupling of voltage-sensing to pore opening in Cav1.3 L-type Ca(2+) channels. Biophysical journal 106, 1467-1475 (2014).
36. Perez-Reyes, E. Molecular physiology of low-voltage-activated t-type calcium channels. Physiol Rev 83, 117-161 (2003).
37. Parkinson Study G. Phase II safety, tolerability, and dose selection study of isradipine as a potential disease-modifying intervention in early Parkinson's disease (STEADY-PD). Mov Disord 28, 1823-1831 (2013).
38. Simuni, T. et al. Tolerability of isradipine in early Parkinson's disease: a pilot dose escalation study. Mov Disord 25, 2863-2866 (2010).
39. Borgkvist, A., Mosharov, E. V. & Sulzer, D. Calcium currents regulate dopamine autoreceptors. Brain 137, 2113-2115 (2014).
40. Branch, S. Y., Sharma, R. & Beckstead, M. J. Aging decreases L-type calcium channel currents and pacemaker firing fidelity in substantia nigra dopamine neurons. J Neurosci 34, 9310-9318 (2014).
41. Puopolo, M., Raviola, E. & Bean, B. P. Roles of subthreshold calcium current and sodium current in spontaneous firing of mouse midbrain dopamine neurons. J Neurosci 27, 645-656 (2007).
42. 2+ selectivity, drives pacemaker activity and amplifies bursts in nigral dopamine neurons. J Neurosci 29, 15414-15419 (2009).
43. Dragicevic, E., Schiemann, J. & Liss, B. Dopamine midbrain neurons in health and Parkinson's disease: Emerging roles of voltagegated calcium channels and ATP-sensitive potassium channels. Neuroscience 284C, 798-814 (2015).
44. Vandael, D. H. et al. Ca(v)1.3 and BK channels for timing and regulating cell firing. Mol Neurobiol 42, 185-198 (2010).
45. Foehring, R. C., Zhang, X. F., Lee, J. C. & Callaway, J. C. Endogenous calcium buffering capacity of substantia nigral dopamine neurons. J Neurophysiol 102, 2326-2333 (2009).
46. Wolfart, J., Neuhoff, H., Franz, O. & Roeper, J. Differential expression of the small-conductance, calcium-activated potassium channel SK3 is critical for pacemaker control in dopaminergic midbrain neurons. J Neurosci 21, 3443-3456 (2001).
47. Jones, S. L. & Stuart, G. J. Different calcium sources control somatic versus dendritic SK channel activation during action potentials. J Neurosci 33, 19396-19405 (2013).
48. 2+ elevation during agonist stimulation. J Biol Chem 278, 10807-10815 (2003).
49. Rudolph, S. & Thanawala, M. S. Location matters: somatic and dendritic SK channels answer to distinct calcium signals. J Neurophysiol 114, 1-5 (2015).
50. Catterall, W. A., Perez-Reyes, E., Snutch, T. P. & Striessnig, J. International Union of Pharmacology. XLVIII. Nomenclature and structure-function relationships of voltage-gated calcium channels. Pharmacol Rev 57, 411-425 (2005).
51. Kabbani, N., Woll, M. P., Nordman, J. C. & Levenson, R. Dopamine receptor interacting proteins: targeting neuronal calcium sensor-1/D2 dopamine receptor interaction for antipsychotic drug development. Current drug targets 13, 72-79 (2012).
52. Wisniewska, M. B. et al. LEF1/beta-catenin complex regulates transcription of the Cav3.1 calcium channel gene (Cacna1g) in thalamic neurons of the adult brain. J Neurosci 30, 4957-4969 (2010).
53. Zhang, H. et al. Ca1.2 and CaV1.3 neuronal L-type calcium channels: differential targeting and signaling to pCREB. Eur J Neurosci 23, 2297-2310 (2006).
54. Lu, L. et al. Regulation of gene transcription by voltage-gated L-type calcium channel, Cav1.3. J Biol Chem 290, 4663-4676 (2015).
55. 2+ tolerance in fission yeast. J Biol Chem 285, 4405-4414 (2010).
56. Khaliq, Z. M. & Bean, B. P. Pacemaking in dopaminergic ventral tegmental area neurons: depolarizing drive from background and voltage-dependent sodium conductances. J Neurosci 30, 7401-7413 (2010).
57. Bean, B. P. The action potential in mammalian central neurons. Nat Rev Neurosci 8, 451-465 (2007).
58. Sanchez-Padilla, J. et al. Mitochondrial oxidant stress in locus coeruleus is regulated by activity and nitric oxide synthase. Nat Neurosci 17, 832-840 (2014).
59. West, A. E. et al. Calcium regulation of neuronal gene expression. Proc Natl Acad Sci USA 98, 11024-11031 (2001).
60. Satin, J., Schroder, E. A. & Crump, S. M. L-type calcium channel auto-regulation of transcription. Cell Calcium 49, 306-313 (2011).
61. Michel, P. P., Toulorge, D., Guerreiro, S. & Hirsch, E. C. Specific needs of dopamine neurons for stimulation in order to survive: implication for Parkinson disease. FASEB J 27, 3414-3423 (2013).
62. Goldberg, M. S. et al. Nigrostriatal dopaminergic deficits and hypokinesia caused by inactivation of the familial Parkinsonismlinked gene DJ-1. Neuron 45, 489-496 (2005).
63. Rice, R. A., Berchtold, N. C., Cotman, C. W. & Green, K. N. Age-related downregulation of the CaV3.1 T-type calcium channel as a mediator of amyloid beta production. Neurobiol Aging 35, 1002-1011 (2014).
64. 2+ channels. Cell 102, 89-97 (2000).
65. Bock, G. et al. 138.12 Cav1.3-deficiency is not neuroprotective in a mouse 6-hydroxydopamine model of Parkinson's disease. In: SfN Meeting Neuroscience 2014 (ed^(eds) (2014).
66. R-Development-Core-Team. R: A Language and Environment for Statistical Computing. (ed^(eds). R Foundation for Statistical Computing (2009).
67. Holt, G. R., Softky, W. R., Koch, C. & Douglas, R. J. Comparison of discharge variability in vitro and in vivo in cat visual cortex neurons. J Neurophysiol 75, 1806-1814 (1996).